Please use this identifier to cite or link to this item:
Title: Cohort profile: Extended Cohort for E-health, Environment and DNA (EXCEED).
Authors: John, C
Reeve, NF
Free, RC
Williams, AT
Farmaki, A-E
Bethea, J
Barton, LM
Shrine, N
Batini, C
Packer, R
Terry, S
Hargadon, B
Wang, Q
Melbourne, CA
Adams, EL
Bee, CE
Harrington, K
Miola, J
Brunskill, NJ
Brightling, CE
Barwell, J
Wallace, SE
Hsu, R
Shepherd, DJ
Hollox, EJ
Wain, LV
Tobin, MD
First Published: 7-May-2019
Publisher: Oxford University Press (OUP) for International Epidemiological Association.
Citation: International Journal of Epidemiology, 2019, dyz073
Abstract: [First paragraph] EXCEED aims to develop understanding of the genetic, environmental and lifestyle-related causes of health and disease. Cohorts like EXCEED, with broad consent to study multiple phenotypes related to onset and progression of disease and drug response, have a role to play in medicines development, by providing genetic evidence that can identify, support or refute putative drug efficacy or identify possible adverse effects.1 Furthermore, such cohorts are well suited to the study of multimorbidity.
DOI Link: 10.1093/ije/dyz073
eISSN: 1464-3685
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © the authors, 2019. This is an open-access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Description: Participants have consented to their pseudonymized data being made available to other approved researchers, and we welcome requests for collaboration and data access. Access to the resource requires completion of a proposal form, including a lay summary of the proposed research. Applications to access the resource will be assessed for consistency with the data access policy and with the guidance of the Scientific Committee, which has participant representation. Access to the data will be subject to completion of an appropriate Data/Materials Transfer Agreement and to necessary funding being in place. Requests to collect new data or to use biological samples may be subject to additional requirements. Interested researchers are encouraged to contact the study management team via
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
File Description SizeFormat 
dyz073.pdfPublished (publisher PDF)541.94 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.